Acute Decompensated Heart Failure (ADHF): Clinical Trials

16 trials for Acute Decompensated Heart Failure (ADHF), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 not yet recruiting, 4 completed, 3 active not recruiting, 1 recruiting. 8 Not applicable, 3 Phase 3, 3 Phase 4, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable8Not yet recruiting 4, Active not recruiting 1, Completed 1, Terminated 1, Unknown 1
Phase 33Completed 1, Not yet recruiting 1, Recruiting 1
Phase 43Completed 2, Active not recruiting 1
Phase 22Completed 1, Not yet recruiting 1

Follow Acute Decompensated Heart Failure (ADHF): new trials by email Literature Review of Acute Decompensated Heart Failure (ADHF) trials Research Report on Acute Decompensated Heart Failure (ADHF)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of FlowMod System While Intermittently Partially Occluding Vena Cava Blood Flow in Subjects With ADHF
FlowMod System in subjects with acute decompensated heart failure (ADHF) - Acute Decompensated Heart Failure (ADHF)
Not applicableNot yet recruitingFlowMod, Inc.302026-09-052026-09-09
Bedside NT-proBNP Monitoring in Acute Heart Failure
Serial NT-proBNP Measurement - Acute Decompensated Heart Failure (ADHF)
Not yet recruitingMao Chen502026-08-152026-08-13
Efficacy and Safety of Compression Boots in Patients With Acute Decompensated Heart Failure.
Pulsatile Compression Boots (PCB) - Acute Decompensated Heart Failure (ADHF)
Not applicableNot yet recruitingOdense University Hospital1002026-01-012026-01-29
Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure
Empagliflozin 10 MG Oral Tablet [Jardiance], Placebo - Acute Decompensated Heart Failure (ADHF)
Phase 3RecruitingChristian Schulze5362025-12-082026-11-04
Levosimendan in Acute Decompensated Heart Failure
Levosimendan, Standard care - Acute Decompensated Heart Failure (ADHF)
Phase 2 / Phase 3Not yet recruitingChittagong Medical College3322025-12-012025-12-04
The Effect of Dapagliflozin on Patients With Cardiomyopathy
Dapagliflozin (DAPA), Diuretic - Acute Decompensated Heart Failure (ADHF)
Phase 4CompletedMay Mohamed Abdalla1002025-08-012026-09-15
ExCR's Effects and Safety in Vulnerable ADHF Patients
Exercise rehabilitation, Conventional rehabilitation - Acute Decompensated Heart Failure (ADHF)
Not applicableNot yet recruitingYE Jing882025-02-172025-01-28
Bedside Ultrasound-guided Volume Management and Discharge Timing for Patients With Heart Failure During Hospitalization: A Randomized Controlled Trial
Ultrasound-Guided Volume Assessment and Decongestion Strategy (UVADS), clinical assessment - Acute Decompensated Heart Failure (ADHF)
Not applicableActive not recruitingPan He1502025-02-012025-07-01
Left Ventricular Impella Device Real-World Evaluation in Pediatric Patients
Impella CP with SmartAssist, Impella 5.5 with SmartAssist - Cardiogenic Shock, Heart Failure
Active not recruitingAbiomed Inc.602024-12-032026-11-17
Noninvasive Assessment of Pulmonary Fluid Levels by Remote Dielectric Sensing Technology to Improve Cardiac InsUfficieney During Ischemia-Reperfusion and Clinical Outcomes in MyocArdiaL Infarction
Remote dielectric sensing system - Acute Myocardial Infarction, Acute Decompensated Heart Failure (ADHF)
Not applicableNot yet recruitingShanghai 10th People's Hospital20002024-11-012024-11-04
Comparison of the Effectiveness of Different Diuretic Therapies in the Management of Acute Heart Failure
Furosemide Bolus, Furosemide Continuous İnfusion - Acute Decompensated Heart Failure (ADHF)
Not applicableCompletedSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey502024-04-032026-03-11
Natriuresis With Acetazolamide or SGLT2 Inhibitors Added to Intravenous Loop Diuretics in Decompensated Heart Failure
Furosemide, Acetazolamide, Dapagliflozin - Heart Failure, Acute Decompensated Heart Failure (ADHF)
Phase 4Active not recruitingUniversidade do Porto682024-03-112026-11-09
Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure
Sacubitril / Valsartan, Ramipril (ACE-inhibitor) - Acute Decompensated Heart Failure (ADHF), Chronic Kidney Disease (CKD)
Phase 2 / Phase 3CompletedNational Heart Institute, Egypt5152023-11-012026-08-13
Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function
Levosimendan, Dobutamine, Milrinone - Acute Decompensated Heart Failure (ADHF), Cardiorenal Syndrome (CRS)
Phase 4CompletedAin Shams University602022-06-012026-09-21
Acute Congestive Heart Failure
non-invasive respiratory parameter measurements - Acute Decompensated Heart Failure (ADHF), Acute Cardiogenic Pulmonary Edema (ACPE)
Not applicableUnknownRWTH Aachen University502013-06-012015-09-23
Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
Isolated veno-venous ultrafiltration (AQ), IV Loop Diuretics (LD) - Heart Failure, Cardiac Failure
Not applicableTerminatedNuwellis, Inc.2242012-01-012023-08-29

Narrower conditions

Heart Failure (5)  ·  Cardio-Renal Syndrome (2)  ·  Cardiomyopathies (1)  ·  Myocarditis (1)  ·  Renal Insufficiency, Chronic (1)  ·  Shock, Cardiogenic (1)

Broader conditions

Cardiovascular Diseases (6)  ·  Heart Diseases (6)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Renal Insufficiency (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Heart Failure (1)  ·  Infarction (1)

Interventions

Furosemide (2)  ·  Simendan (2)  ·  dapagliflozin (2)  ·  empagliflozin (2)  ·  Acetazolamide (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Diuretics (1)  ·  Dobutamine (1)  ·  Exercise Therapy (1)  ·  Intermittent Pneumatic Compression Devices (1)  ·  Milrinone (1)  ·  Ramipril (1)  ·  Sodium Potassium Chloride Symporter Inhibitors (1)  ·  Standard of Care (1)  ·  Tablets (1)

Sponsors

Abiomed Inc. (1)  ·  Ain Shams University (1)  ·  Chittagong Medical College (1)  ·  Christian Schulze (1)  ·  FlowMod, Inc. (1)  ·  Mao Chen (1)  ·  May Mohamed Abdalla (1)  ·  National Heart Institute, Egypt (1)  ·  Nuwellis, Inc. (1)  ·  Odense University Hospital (1)  ·  Pan He (1)  ·  RWTH Aachen University (1)  ·  Shanghai 10th People's Hospital (1)  ·  Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey (1)  ·  Universidade do Porto (1)

Countries

China (3)  ·  Egypt (3)  ·  Germany (2)  ·  United States (2)  ·  Bangladesh (1)  ·  Denmark (1)  ·  Georgia (1)  ·  Portugal (1)  ·  Turkey (Türkiye) (1)  ·  Uzbekistan (1)

Top investigators

Baiyu Zhang (1)  ·  Freja S. Madsen, M.D., Ph.D student (1)  ·  Hesham Salah Eldin Taha, MD (1)  ·  Jing Ye, MSN. (1)  ·  Lei Yang (1)  ·  Lihua Zhao, MSN. (1)  ·  Maria Rosa Costanzo, MD (1)  ·  Omar Younis, Msc (1)  ·  Pedro M. Marques, MD (1)  ·  Wenhui Ding, Prof. (1)  ·  Xiaoning Han, Ph.D. (1)  ·  Yidong Wei, M.D., Ph.D. (1)  ·  Yimeng Jiang, Ph.D. (1)  ·  Yuling Wang (1)

Results publications

PMID 40976670, PMID 42624047